We are live on
!
Find out more
KBC Group Portfolio holdings
AUM
$39.9B
1-Year Est. Return
29.7%
This Fund
S&P 500
This Quarter
Est. Return
+1.08%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$27.3B
AUM Growth
-$28.2B
(-51%)
Cap. Flow
-$28.9B
Cap. Flow
% of AUM
-105.88%
Top 10 Holdings %
Top 10 Hldgs %
23.06%
Holding
1,354
New
88
Increased
57
Reduced
1,096
Closed
66
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$36.3M |
| 2 |
Paycom
PAYC
|
+$30.3M |
| 3 |
Airbnb
ABNB
|
+$26.2M |
| 4 |
Charles River Laboratories
CRL
|
+$22.6M |
| 5 |
Bio-Techne
TECH
|
+$22.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.57B |
| 2 |
Amazon
AMZN
|
+$1.15B |
| 3 |
Apple
AAPL
|
+$1.01B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$881M |
| 5 |
Comcast
CMCSA
|
+$482M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.21% |
| 2 | Healthcare | 16.15% |
| 3 | Financials | 15.41% |
| 4 | Consumer Discretionary | 12.5% |
| 5 | Communication Services | 11.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Labcorp
LH
$25.2B
| $64.3M | 0.24% |
265,989
-280,968
| -51% | -$70.8M |
|
|
WRK
102
DELISTED
WestRock Company
WRK
| $63.9M | 0.23% |
1,282,623
-1,198,953
| -48% | -$60.6M |
|
103
Electronic Arts
EA
$52.4B
| $63.6M | 0.23% |
447,032
-420,130
| -48% | -$59M |
|
104
Roper Technologies
ROP
$40.4B
| $63.3M | 0.23% |
141,893
-207,941
| -59% | -$99.6M |
|
105
Citigroup
C
$213B
| $63.1M | 0.23% |
899,454
-807,570
| -47% | -$56.5M |
|
|
SBNY
106
DELISTED
Signature Bank
SBNY
| $62.6M | 0.23% |
229,810
-239,110
| -51% | -$60M |
|
107
DexCom
DXCM
$29B
| $61.8M | 0.23% |
452,052
-410,940
| -48% | -$51.8M |
|
108
State Street
STT
$48.4B
| $61.5M | 0.23% |
725,882
-425,138
| -37% | -$37M |
|
109
Texas Instruments
TXN
$248B
| $61.3M | 0.22% |
318,722
-203,266
| -39% | -$38.7M |
|
110
Ametek
AME
$53.9B
| $61.1M | 0.22% |
492,875
-504,323
| -51% | -$67.7M |
|
111
Moderna
MRNA
$21.6B
| $60.5M | 0.22% |
157,270
-65,474
| -29% | -$24.1M |
|
112
Newmont
NEM
$96.2B
| $60.4M | 0.22% |
1,112,451
-1,022,727
| -48% | -$60.3M |
|
113
AT&T
T
$164B
| $59.9M | 0.22% |
2,937,825
-3,252,029
| -53% | -$68.3M |
|
114
TJX Companies
TJX
$179B
| $59.9M | 0.22% |
907,695
-1,508,475
| -62% | -$105M |
|
115
Hilton Worldwide
HLT
$72.4B
| $59.4M | 0.22% |
449,432
-184,260
| -29% | -$23.3M |
|
116
Coca-Cola
KO
$383B
| $59.3M | 0.22% |
1,130,930
-3,469,406
| -75% | -$193M |
|
117
Zurn Elkay Water Solutions
ZWS
$8.6B
| $59.1M | 0.22% |
1,908,571
-925,098
| -33% | -$25.9M |
|
118
American Water Works
AWK
$27B
| $59M | 0.22% |
348,944
-326,726
| -48% | -$57.1M |
|
119
Humana
HUM
$43.9B
| $58.1M | 0.21% |
149,232
-199,872
| -57% | -$84.8M |
|
120
Dell
DELL
$239B
| $58M | 0.21% |
1,099,223
-1,160,556
| -51% | -$57.9M |
|
121
Gilead Sciences
GILD
$165B
| $57.9M | 0.21% |
828,879
-426,903
| -34% | -$30M |
|
122
MetLife
MET
$62.4B
| $57.5M | 0.21% |
932,153
+16,527
| +2% | +$995K |
|
123
CrowdStrike
CRWD
$183B
| $56.8M | 0.21% |
924,196
-1,005,916
| -52% | -$64.9M |
|
124
Intuitive Surgical
ISRG
$127B
| $55.7M | 0.2% |
168,135
-97,677
| -37% | -$32.8M |
|
125
Dover
DOV
$26.7B
| $55.1M | 0.2% |
354,282
-402,434
| -53% | -$66.7M |
|
Similar funds
HF
KBC Group's Q3 2021 Portfolio in Review
As of Q3 2021, KBC Group held 1,354 positions worth $27.3B, down 51% from $55.5B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
KBC Group withdrew a net $28.9B in Q3 2021, closing 66 positions and reducing 1,096 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $42.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
Against the trend, KBC Group opened a new position in DoorDash worth $9.43M.
- KBC Group's largest Q3 2021 buy was DoorDash: 45,764 shares worth $9.43M.
- KBC Group added most to Zscaler in Q3 2021, an estimated $36.3M increase.
- KBC Group's biggest Q3 2021 reduction was Microsoft, cutting an estimated $1.57B.
- KBC Group fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $42.6M.
- KBC Group's ten largest holdings make up 23% of its $27.3B portfolio in Q3 2021.
- KBC Group opened 88 new positions and closed 66 in Q3 2021.
- KBC Group's portfolio value fell 51% quarter-over-quarter to $27.3B.
Based on KBC Group's 13F filing for Q3 2021, filed 10 Nov 2021.